Literature DB >> 26990165

Editorial: Pursuit of a Dual-Benefit Antigout Drug: A First Look at Arhalofenate.

Tuhina Neogi1, Hyon K Choi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26990165      PMCID： PMC4982369          DOI： 10.1002/art.39687

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  11 in total

1.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Authors:  Kelsey M Jordan; J Stewart Cameron; Michael Snaith; Weiya Zhang; Michael Doherty; Jonathan Seckl; Aroon Hingorani; Richard Jaques; George Nuki
Journal:  Rheumatology (Oxford)       Date:  2007-05-23       Impact factor: 7.580

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 3.  Clinical practice. Gout.

Authors:  Tuhina Neogi
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

4.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

5.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

6.  Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.

Authors:  Hyon K Choi; Earl S Ford; Chaoyang Li; Gary Curhan
Journal:  Arthritis Rheum       Date:  2007-02-15

Review 7.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

8.  Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.

Authors:  Frances Rees; Wendy Jenkins; M Doherty
Journal:  Ann Rheum Dis       Date:  2012-06-07       Impact factor: 19.103

Review 9.  Gout: why is this curable disease so seldom cured?

Authors:  Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Fernando Perez-Ruiz; Leonardo Punzi; Alexander K So; Thomas Bardin
Journal:  Ann Rheum Dis       Date:  2012-08-03       Impact factor: 19.103

10.  A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout.

Authors:  Jeffrey Poiley; Alexandra S Steinberg; Yun-Jung Choi; Charles S Davis; Robert L Martin; Charles A McWherter; Pol F Boudes
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995
View more
  2 in total

Review 1.  Urate transport in health and disease.

Authors:  Victoria L Halperin Kuhns; Owen M Woodward
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-10-21       Impact factor: 4.098

Review 2.  A glance into the future of gout.

Authors:  Francisca Sivera; Mariano Andres; Nicola Dalbeth
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-28       Impact factor: 3.625
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.